Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial. Dillinger JG, Pezel T, Batias L, Angoulvant D, et al. Eur Heart J 2025 Aug 30:ehaf680. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dillinger JG, Pezel T, Batias L, Angoulvant D, et al. Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial. Eur Heart J 2025 Aug 30:ehaf680. doi: 10.1093.
PMID: 40884757